The grant, in collaboration with the Kentucky Department for Public Health, provides opportunities to strengthen ongoing efforts to combat Kentucky’s drug overdose crisis and reduce overdose-related harms.
The $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) will support research to understand how xylazine and fentanyl change the brain’s signaling pathways.
Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.
Aug. 31 marks International Overdose Awareness Day, a time when attention is directed toward raising awareness about opioid overdose and ways to reverse deadly effects. One such way is naloxone, which has become more available throughout Kentucky due to UK’s HEALing Communities Study.
The Foundation for Opioid Response Efforts (FORE) has selected the University of Kentucky College of Pharmacy as one of three higher education entities funded to improve access to medications for opioid use disorder in pharmacies and health care settings.
A new study suggests that children born to mothers who use opioids during pregnancy may be more likely to develop chronic diseases as adults, including cardiovascular and metabolic diseases.
University of Kentucky researchers are creating an innovative statewide surveillance system to inform prevention and response efforts aimed at reducing the burden of opioid use disorder in Kentucky.
FindHelpNow is a near-real-time substance use disorder treatment locator created by the University of Kentucky College of Public Health’s Kentucky Injury Prevention and Research Center (KIPRC).
